Manufacturer’s reply to letter on risk of hyperkalaemia with low sodium saltBMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d5049 (Published 16 August 2011) Cite this as: BMJ 2011;343:d5049
- Leslie T Wilson, director1
- 1Low Sodium Sea Salt Company, Bromley, Kent, UK
A high magnesium and potassium sea salt with the SOLO formulation underwent a randomised double blind placebo trial at Erasmus University Medical School in the Netherlands in 1994 and the positive results (reduction in blood pressure in those consumers with mild to moderate hypertension) …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial